Skip to main content
Top

10-04-2024 | Stroke | REVIEW

Sweet Surprises: An In-depth Systematic Review of Artificial Sweeteners and Their Association with Cerebrovascular Accidents

Authors: Khushal B. Girigosavi, Indu Etta, Saisravika Kambham, Binay K. Panjiyar

Published in: Current Nutrition Reports

Login to get access

Abstract

Purpose of Review

Artificial sweeteners have become increasingly popular in today’s dietary trends as a healthier and sweeter alternative to sugar. As studies emerge regarding artificial sweeteners, concerns are arising about their side effects, particularly linking them to strokes. This systematic review aims to assess the relationship between artificial sweeteners (AS) and cerebrovascular accidents (CVAs). A systematic search of studies indexed in PubMed and Google Scholar was conducted using the keywords “ASB” (artificially sweetened beverage), “Artificial Sweeteners,” “Stroke,” etc. These studies were screened and filtered according to our exclusion criteria. We reviewed 55 studies published in various journals and further boiled down to finalizing 12 studies for analysis using the PRISMA Statement (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020.

Recent Findings

Most studies suggest that there is a positive association between artificial sweetener consumption and CVAs including all types of strokes, particularly ischemic strokes. Poorer outcomes are seen with higher ASB intake. Increased risk is notable among women and black populations. Some studies show no association between ASB consumption and hemorrhagic stroke, however, most suggest a strong link.

Summary

The current literature shows a degree of variation so it is crucial to consider possible confounders and eliminate them in future studies. Further research is necessary to determine the underlying mechanisms, especially in individuals with comorbidities. The results obtained play a role in forming dietary guidelines and alarming the public about the possible health implications, prompting caution regarding excessive consumption of artificial sweeteners, in their daily lives.
Literature
1.
go back to reference Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W, et al. World Stroke Organization (WSO): global stroke fact sheet 2022. Int J Stroke. 2022;17(1):18–29.CrossRefPubMed Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W, et al. World Stroke Organization (WSO): global stroke fact sheet 2022. Int J Stroke. 2022;17(1):18–29.CrossRefPubMed
3.
go back to reference Tsao CW, Aday AW, Almarzooq ZI, Beaton AZ, Bittencourt MS, Boehme AK, et al. Heart disease and stroke statistics—2023 update: a report from the American Heart Association. Circulation. 2023;147:e93–621.CrossRefPubMed Tsao CW, Aday AW, Almarzooq ZI, Beaton AZ, Bittencourt MS, Boehme AK, et al. Heart disease and stroke statistics—2023 update: a report from the American Heart Association. Circulation. 2023;147:e93–621.CrossRefPubMed
5.
go back to reference O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388:761–75.CrossRefPubMed O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388:761–75.CrossRefPubMed
6.
go back to reference Ma YH, Leng XY, Dong Y, Xu W, Cao XP, Ji X, et al. Risk factors for intracranial atherosclerosis: a systematic review and meta-analysis. Atherosclerosis. 2019;281:71–7.CrossRefPubMed Ma YH, Leng XY, Dong Y, Xu W, Cao XP, Ji X, et al. Risk factors for intracranial atherosclerosis: a systematic review and meta-analysis. Atherosclerosis. 2019;281:71–7.CrossRefPubMed
7.
go back to reference Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics–2015 update: a report from the American Heart Association. Circulation. 2015;131:e29-322.PubMed Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics–2015 update: a report from the American Heart Association. Circulation. 2015;131:e29-322.PubMed
12.
go back to reference FDA Agency Response Letter GRAS Notice No. GRN 000738 [THAUMATIN sweetener and food flavor modifier] (2018). FDA Agency Response Letter GRAS Notice No. GRN 000738 [THAUMATIN sweetener and food flavor modifier] (2018).
23.
go back to reference •• Li B, Yan N, Jiang H, Cui M, Wu M, Wang L, Mi B, Li Z, Shi J, Fan Y, Azalati MM, Li C, Chen F, Ma M, Wang D, Ma L. Consumption of sugar sweetened beverages, artificially sweetened beverages and fruit juices and risk of type 2 diabetes, hypertension, cardiovascular disease, and mortality: a meta-analysis Front Nutr. 2023;10:1019534. https://doi.org/10.3389/fnut.2023.1019534. This meta-analysis includes 16 studies, 2 of which show a significant and direct association between ASB consumption and stroke, while 10 of the studies show a significant association [1.32 (1.11–1.56)] of ASB intake with T2D and 4 of them contribute to the development of HTN [1.14(1.10–1.18)], thus affecting the outcome of stroke directly or indirectly. •• Li B, Yan N, Jiang H, Cui M, Wu M, Wang L, Mi B, Li Z, Shi J, Fan Y, Azalati MM, Li C, Chen F, Ma M, Wang D, Ma L. Consumption of sugar sweetened beverages, artificially sweetened beverages and fruit juices and risk of type 2 diabetes, hypertension, cardiovascular disease, and mortality: a meta-analysis Front Nutr. 2023;10:1019534. https://​doi.​org/​10.​3389/​fnut.​2023.​1019534This meta-analysis includes 16 studies, 2 of which show a significant and direct association between ASB consumption and stroke, while 10 of the studies show a significant association [1.32 (1.11–1.56)] of ASB intake with T2D and 4 of them contribute to the development of HTN [1.14(1.10–1.18)], thus affecting the outcome of stroke directly or indirectly.
24.
go back to reference • Pacheco LS, Tobias DK, Li Y, Bhupathiraju SN, Willett WC, Ludwig DS, Ebbeling CB, Haslam DE, Drouin-Chartier J-P, Hu FB, Guasch-Ferré M. Sugar- or artificially-sweetened beverage consumption, physical activity, and risk of cardiovascular disease in US adults. In United States. 2023. https://doi.org/10.1101/2023.04.17.23288711. This study uses Cox proportional-hazard models to calculate HR from the NHS and HPFS pool and excludes subjects with a baseline history of CVD, diabetes mellitus, and cancer. It adjusts the HR according to age, BMI, physical activity (US guidelines), smoking, calorie intake, and TV consumption, thus depicting ASB intake and its risks among the general healthy population. • Pacheco LS, Tobias DK, Li Y, Bhupathiraju SN, Willett WC, Ludwig DS, Ebbeling CB, Haslam DE, Drouin-Chartier J-P, Hu FB, Guasch-Ferré M. Sugar- or artificially-sweetened beverage consumption, physical activity, and risk of cardiovascular disease in US adults. In United States. 2023. https://​doi.​org/​10.​1101/​2023.​04.​17.​23288711This study uses Cox proportional-hazard models to calculate HR from the NHS and HPFS pool and excludes subjects with a baseline history of CVD, diabetes mellitus, and cancer. It adjusts the HR according to age, BMI, physical activity (US guidelines), smoking, calorie intake, and TV consumption, thus depicting ASB intake and its risks among the general healthy population.
25.
go back to reference • Krittanawong C, Qadeer YK, Wang Z, Nadolsky K, Virani S, Lavie CJ. Sugar-sweetened and artificially sweetened beverages consumption and risk of cardiovascular health. Am J Med. 2023;136(2):163–171. https://www.amjmed.com/article/S0002-9343(22)00737-9/pdf. This study focuses on 16 prospective studies and after analysis using DerSimonian and Laird random-effects method concludes that ASB intake is associated with increased risk of stroke, CVD. Higher intake is associated with worse outcomes. • Krittanawong C, Qadeer YK, Wang Z, Nadolsky K, Virani S, Lavie CJ. Sugar-sweetened and artificially sweetened beverages consumption and risk of cardiovascular health. Am J Med. 2023;136(2):163–171. https://​www.​amjmed.​com/​article/​S0002-9343(22)00737-9/​pdfThis study focuses on 16 prospective studies and after analysis using DerSimonian and Laird random-effects method concludes that ASB intake is associated with increased risk of stroke, CVD. Higher intake is associated with worse outcomes.
26.
go back to reference •• Yang B, Glenn AJ, Liu Q, Madsen T, Allison MA, Shikany JM, Manson JE, Chan KHK, Wu W-C, Li J, Liu S, Lo K. Added sugar, sugar-sweetened beverages, and artificially sweetened beverages and risk of cardiovascular disease: findings from the Women’s Health Initiative and a network meta-analysis of prospective studies. Nutrients. 2022;14(20). https://doi.org/10.3390/nu14204226. This study includes findings from the WHI-OS study which focused on 109,034 postmenopausal women who were followed up till March 2021 after adjusting for confounders like baseline history of DM, cancer, and CVD among a few others. It also includes 21 prospective cohort studies, both of which show a significant association between ASB intake and stroke. •• Yang B, Glenn AJ, Liu Q, Madsen T, Allison MA, Shikany JM, Manson JE, Chan KHK, Wu W-C, Li J, Liu S, Lo K. Added sugar, sugar-sweetened beverages, and artificially sweetened beverages and risk of cardiovascular disease: findings from the Women’s Health Initiative and a network meta-analysis of prospective studies. Nutrients. 2022;14(20). https://​doi.​org/​10.​3390/​nu14204226This study includes findings from the WHI-OS study which focused on 109,034 postmenopausal women who were followed up till March 2021 after adjusting for confounders like baseline history of DM, cancer, and CVD among a few others. It also includes 21 prospective cohort studies, both of which show a significant association between ASB intake and stroke.
Metadata
Title
Sweet Surprises: An In-depth Systematic Review of Artificial Sweeteners and Their Association with Cerebrovascular Accidents
Authors
Khushal B. Girigosavi
Indu Etta
Saisravika Kambham
Binay K. Panjiyar
Publication date
10-04-2024
Publisher
Springer US
Published in
Current Nutrition Reports
Electronic ISSN: 2161-3311
DOI
https://doi.org/10.1007/s13668-024-00537-9
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.